B. J. Kennedy
#47,072
Most Influential Person Now
American physician
B. J. Kennedy's AcademicInfluence.com Rankings
B. J. Kennedyphilosophy Degrees
Philosophy
#5722
World Rank
#8609
Historical Rank
Logic
#3011
World Rank
#4103
Historical Rank
Download Badge
Philosophy
B. J. Kennedy's Degrees
- Doctorate Medicine Harvard University
Why Is B. J. Kennedy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Byrl James "B.J." Kennedy was an American physician who is considered to be the "Father of Medical Oncology." Born in Plainview, Minnesota, in 1921, B.J. Kennedy received his MD from the University of Minnesota Medical School. He served his residency at Massachusetts General Hospital and received further training at McGill University and Cornell Medical College.
B. J. Kennedy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer of the stomach. A patient care study by the American College of Surgeons. (1993) (690)
- Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. (1983) (281)
- Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. (1981) (267)
- Skin changes secondary to hydroxyurea therapy. (1975) (227)
- Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. (1978) (206)
- Tamoxifen (antiestrogen) therapy in advanced breast cancer. (1977) (157)
- IMPACT OF DELAY IN DIAGNOSIS ON CLINICAL STAGE OF TESTICULAR CANCER (1981) (153)
- Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin (1985) (150)
- Group counseling in adult patients with advanced cancer (1979) (145)
- Metabolic and toxic effects of mithramycin during tumor therapy. (1970) (142)
- Increased erythropoiesis induced by androgenic-hormone therapy. (1957) (140)
- Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. (1997) (118)
- Hydroxyurea therapy in chronic myelogenous leukemia (1972) (113)
- Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. (1997) (110)
- T N M classification for stomach cancer (1970) (110)
- Accelerated growth of testicular cancer after cytoreductive surgery (1980) (109)
- Binding characteristics of zearalenone analogs to estrogen receptors. (1978) (102)
- Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. (1966) (100)
- Hydroxyurea inhibition of DNA synthesis in ascites tumor. (1965) (96)
- Gastric carcinoma: does lymph node dissection alter survival? (1996) (94)
- Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy. (1970) (92)
- Mithramycin inhibition of ribonucleic acid synthesis. (1966) (89)
- Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors. (1982) (88)
- Effects of intensive sex steroid hormone therapy in advanced breast cancer. (1953) (85)
- Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. (1982) (85)
- Fluoxymesterone therapy in advanced breast cancer. (1958) (84)
- Mithramycin therapy in advanced testicular neoplasms (1970) (82)
- VP-16-213 (etoposide): the mandrake root from Issyk-Kul. (1982) (82)
- Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. (1982) (81)
- Lack of age-dependent cisplatin nephrotoxicity. (1984) (80)
- Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma. Possible importance of longer induction and shorter maintenance schedules. (1980) (77)
- Regression of metastatic renal cell carcinoma following nephrectomy (1972) (77)
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5‐drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B study (1984) (77)
- Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies. (2012) (75)
- Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma. (1980) (73)
- Daunomycin inhibition of DNA and RNA synthesis (1968) (72)
- Hypercalcemia, a complication of hormone therapy of advanced breast cancer. (1953) (70)
- Occurrence of peritonitis during ACTH administration. (1950) (68)
- Marker half-life analysis as a prognostic tool in testicular cancer. (1982) (68)
- Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group B (1980) (68)
- The Unified International Gastric Cancer Staging Classification System (1987) (65)
- Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts. (1983) (64)
- Combination versus successive single agent chemotherapy in lymphocytic lymphoma (1978) (62)
- Estrogen receptor assay in the differential diagnosis of adenocarcinomas. (1977) (61)
- Coronary artery disease after treatment with bleomycin and vinblastine. (1980) (58)
- Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. (1982) (55)
- Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy (2004) (53)
- Evaluation of AJC stomach cancer staging using the SEER population. (1985) (52)
- Tumor markers in advanced nonseminomatous testicular cancer (1981) (51)
- Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. (1989) (51)
- Mechanism of the hypocalcemic effect of mithramycin. (1979) (48)
- THERAPEUTIC CASTRATION VERSUS PROPHYLACTIC CASTRATION IN BREAST CANCER. (1964) (48)
- Studies on the neutropenia of cancer chemotherapy (1974) (46)
- Cephalothin, carbenicillin, and gentamicin combination therapy for febrile patients with acute non‐lymphocytic leukemia (1974) (45)
- Mediastinal nonseminomatous germ cell tumors: the role of combined modality therapy. (1982) (45)
- Hodgkin's disease in the bone marrow (1975) (45)
- A randomized trial of chemotherapy and hormonal therapy in advanced breast cancer. (1985) (41)
- Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. (1982) (41)
- A progestogen for treatment of advanced endometrial cancer. (1963) (41)
- Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer (1981) (41)
- Cancer staging. (1979) (40)
- Effect of mithramycin on a mouse glioma. (1968) (40)
- Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia (1982) (40)
- Combined chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP (1976) (39)
- Patient recall of informed consent. (1979) (38)
- Hypophysectomy in advanced breast cancer. (1965) (37)
- Long-term follow-up of stage III testicular carcinoma treated with mithramycin (plicamycin). (1995) (36)
- The evolution of hydroxyurea therapy in chronic myelogenous leukemia. (1992) (36)
- Stage II nonseminomatous testicular cancer: a 10-year experience. (1983) (36)
- Granulocyte Transfusion: A Controlled Study in Patients with Acute Nonlymphocytic Leukemia (2003) (35)
- Hypophysectomy in the treatment of advanced cancer of the male breast (1972) (35)
- Chronic myelogenous leukemia presenting in blastic crisis (1972) (34)
- Nephrotoxicity of continuous intravenous infusion of recombinant interleukin-2. (1988) (34)
- BIOLOGICAL AND HISTOLOGICAL CHARACTERISTICS OF SIMULTANEOUS BILATERAL BREAST CANCER (1980) (33)
- Tumor classification and size in germ‐cell testicular cancer. Influence on the occurrence of metastases (1982) (33)
- Pathology of primary and recurrent carcinoma of the human breast after administration of steroid hormones (1953) (33)
- Surgical treatment of patients with stages I and II nonseminomatous testicular cancer. (1985) (33)
- Treatment of testicular cancer. (1985) (30)
- Lymphosarcoma terminating in acute myelogenous leukemia (1972) (30)
- Effect of androgenic hormone in myelofibrosis. (1962) (29)
- Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia (1973) (28)
- Sustained complete remission of metastatic sweat gland carcinoma following regional hyperthermic perfusion. (1978) (28)
- Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin. (1980) (28)
- Acute Changes of a-Fetoprotein and Human Chorionic Gonadotropinduring InductionChemotherapy of Germ Cell Tumors1 (1982) (27)
- Biochemical alterations during steroid hormone therapy of advanced breast cancer. (1955) (27)
- Studies with tritiated mithramycin in C3H mice. (1967) (27)
- Effect of adrenocorticotropic hormone (ACTH) on beryllium granulomatosis and silicosis. (1951) (26)
- Cyclic biological expression in mouse mammary tumors. (1982) (26)
- Mithramycin therapy in testicular cancer. (1972) (26)
- National survey of patterns of care for testis cancer (1987) (25)
- Hypersensitivity Reactions to Etoposide A Case Report and Review of the Literature (1988) (25)
- Combination of cyclophosphamide and estrogen therapy in dmba‐induced rat mammary cancer (1971) (24)
- Cyclophosphamide, doxorubicin, vincristine, and low‐dose continuous infusion bleomycin in non‐Hodgkin's lymphoma: Cancer and leukemia group B study #7804 (1982) (24)
- Daunorubicine in acute myelogenous leukemia in adults. (1969) (24)
- Adjuvant systemic therapy (1990) (24)
- Daunorubicin-prednisone treatment of erythroleukemia. (1974) (24)
- Staging of gastric cancer. (1985) (23)
- Effect of mithramycin on HeLa cells (1968) (23)
- Poor prognosis of mediastinal germ cell cancers containing sarcomatous components. (1990) (23)
- MELANOMA IN AN ALBINO. (1963) (22)
- Progestogens in the treatment of carcinoma of the endometrium. (1968) (22)
- HYPOPHYSECTOMY IN ADVANCED BREAST CANCER. (1956) (22)
- Continuous Flow Centrifuge Leucapheresis in the Management of Chronic Myelogenous Leukaemia (1975) (21)
- Survival in Hodgkin's disease by stage and age. (1992) (21)
- Surgery as an adjunct to hormone therapy of breast cancer (1957) (20)
- Successful treatment of mediastinal germ cell/endodermal sinus tumors. (1985) (20)
- Poor prognosis of mediastinal germ cell cancers containing sarcomatous components (1990) (19)
- Extirpative endocrine therapy for advanced cancer of the breast. (1956) (19)
- A factor from HeLa cells promoting colonial growth of human fibroblast-like cells in culture. (1963) (19)
- 5‐Fluorouracil toxicity (1999) (18)
- Daunorubicin therapy in adult acute lymphatic leukemia (1972) (18)
- Mithramycin (NSC-24559) therapy for primary glioblastomas. (1965) (18)
- Breast involvement in acute lymphatic leukemia. Daunorubicine‐induced remission; pneumocystis carinii pneumonia (1970) (18)
- A comparison of the rate of recovery from inhibition of RNA synthesis in mouse liver and transplantable glioma. (1967) (18)
- Oncornavirus-like particles from cultured bone marrow cells preceding leukemia and malignant histiocytosis. (1975) (18)
- 87 Marker Rhythms for Cancer Chrono-chemotherapy (1984) (16)
- Reversal of myelofibrosis in advanced breast cancer. (1978) (16)
- The effect of stanolone in the treatment of advanced breast cancer (1955) (15)
- Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B. (1986) (15)
- The exchangeable character of accumulated I131 in the thyroid gland of a goitrous cretin. (1957) (14)
- Vascular toxicity following vinblastine, bleomycin, and cisplatin therapy for germ cell tumours. (1987) (14)
- The present status of hormone therapy in advanced breast cancer. (1957) (14)
- A phase II study of spirogermanium in advanced human malignancy (1985) (14)
- cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer. (1978) (13)
- Leukemia occurring after treatment of small cell lung cancer. (1982) (13)
- ANDROGENIC HORMONE THERAPY IN LYMPHATIC LEUKEMIA. (1964) (13)
- Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma. (1994) (12)
- Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer. (1980) (12)
- Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone. (1981) (10)
- The effect of adrenocorticotropic hormone on beryllium granulomatosis; a preliminary report. (1950) (10)
- Programmed automatic FUDR chronotherapy improves therapeutic index (1986) (10)
- CCNU‐adriamycin therapy in bronchogenic carcinoma (1978) (10)
- Hormonal therapies in breast cancer. (1974) (10)
- Estrogen Receptors-Reply (1977) (9)
- Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia. (1965) (9)
- Cytosine arabinoside in herpes zoster. (1973) (9)
- Evolution of the International Gastric Cancer Staging Classification (1987) (8)
- Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study. (1983) (8)
- Effect of methenolone enanthate (NSC‐64967) in advanced cancer of the breast (1968) (8)
- Levels of Blood Group Synthetic Enzymes in Human Colonic Carcinoma 1 (1978) (8)
- Endocrine therapy of breast cancer. (1967) (8)
- Management of testicular seminoma following organ transplantation. (1992) (8)
- Vindesine in bronchogenic carcinoma: a phase II trial. (1982) (8)
- DIETHYLSTILBESTROL VERSUS TESTOSTERONE PROPIONATE THERAPY IN ADVANCED BREAST CANCER. (1965) (8)
- Piperazinedione in metastatic renal carcinoma. (1977) (8)
- Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemia. (1975) (7)
- Leukapheresis in the management of chronic leukemia. (1973) (7)
- Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics (1995) (7)
- Effect of urethane, hydroxyurethane and hydroxyurea on synthesis of nucleic acid (1968) (7)
- Correlation of histological alterations in breast cancer with response to hormone therapy (1960) (7)
- Extragonadal Abdominal Germ Cell Cancers (1992) (7)
- Massive estrogen administration in premenopausal women with advanced breast cancer. (1962) (6)
- TREATMENT OF TESTICULAR CANCER (1985) (6)
- Who says it is terminal? (1978) (6)
- Sister-chromatid exchange induction by cis-platinum/adriamycin cancer chemotherapy. (1982) (6)
- The effect of short-term cyclophosphamide on estrogen therapy in metastatic breast cancer. (1975) (6)
- Hydroxyurea in Chronic Myelogenous Leukemia. (1969) (5)
- Effect of androgenic hormone combined with hydroxyurea (NSC-32065) on hematopoietic system of patients with cancer. (1965) (5)
- Medical oncology manpower supply. (1986) (5)
- Hodgkin's disease in the bone marrow (1975) (5)
- Ethyl carbamate (urethane) in the treatment of mycosis fungoides (1950) (5)
- Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer (2005) (4)
- Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats. (1985) (4)
- Alteration of iron metabolism during androgen therapy of advanced breast cancer (1966) (4)
- THE ROLL OF CASTRATION IN BREAST CANCER. (1964) (4)
- New role of endocrine therapy in breast cancer. (1978) (4)
- Optimal Number of Chemotherapy Courses in Advanced Nonseminomatous Testicular Carcinoma (1995) (4)
- Hypophysectomy in the treatment of advanced cancer of the male breast. (1972) (4)
- CCNU, vinblastine, and delalutin therapy in renal cell carcinoma. (1978) (4)
- Effects of Steroids in Women with Breast Cancer1 (1956) (4)
- Specific effect of mithramycin on embryonal carcinoma of the testis. (1965) (4)
- Multiple myeloma. Clinical evolution. (1974) (4)
- Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine. (1980) (4)
- Combination therapy with radiation and mithramycin or actinomycin D in A transplanted mouse glioma (1969) (4)
- A special report. Medical oncology: The new subspecialty† (1975) (4)
- The cell separator. A continuous flow centrifuge for blood component collection. (1973) (3)
- Effect of Mithramycin on Kidney Transamidinase of C3H Mice∗ † (1968) (3)
- Mycosis fungoides followed for fourteen years; the case of Dr. W. B. Cannon. (1955) (3)
- Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia. (1981) (3)
- Reactions to a patient dining room in a cancer parahospital. (1968) (3)
- Laparotomy in the re-evaluation of patients with advanced Hodgkin's disease. (1981) (3)
- Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies. (1989) (3)
- Prognostic factors in cancer of the testis: an approach to identification. (1980) (3)
- The therapeutic indications for nitrogen mustards in lymphoma. (1949) (3)
- The treatment of subacute bacterial endocarditis with penicillin in beeswax-peanut oil; gluteal abscesses and rupture of the spleen. (1947) (3)
- THE CONTROL OF ADVANCED BREAST CANCER. (1963) (2)
- Hydroxyurea-Associated Leg Ulceration (1998) (2)
- Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study. (1979) (2)
- Adjuvant therapy of breast cancer--an overview. (1998) (2)
- Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). (1983) (2)
- DIETHYLSTILBESTROL (NSC-3070) AND TESTOSTERONE PROPIONATE (NSC-9166) THERAPY IN ADVANCED BREAST CANCER. 1. A COMPARISON. (1964) (2)
- Chemoendocrine therapy in advanced breast cancer (2005) (2)
- Mithramycin effect on mouse glioma. A time-study suggesting a method for reducing toxicity. Abstr. (1966) (2)
- Apparent chemotherapeutic cure of malignant lymphoma (1971) (2)
- A novel nanoparticle albumin bound thiocolchicine dimer (nab-5404) with dual mechanisms of action on tubulin and topoisomerase-1: evaluation of in vitro and in vivo activity (2005) (2)
- Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804. (1982) (2)
- Impact of Institutional Review Boards on cancer research (1984) (2)
- Medical student training in medical oncology. (1979) (2)
- Appearance and spread of human breast cancer. (1973) (1)
- Effect of mithramycin on parathyroid hormone production in cancer patients (1975) (1)
- The treatment of melanoma with m‐AMSA A Cancer and Leukemia Group B phase II study (1984) (1)
- Effect of massive doses of sex hormones on libido. (1973) (1)
- GRANULOCYTE TRANSFUSIONS IN ACUTE LEUKÆMIA (1975) (1)
- Combination Chemotherapy with Etoposide and 5-Fluorouracil in Advanced Pancreatic Adenocarcinoma (1989) (1)
- Adjuvant Therapy of Breast Cancer (1998) (1)
- Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study. (1983) (1)
- Letter: Pleasures and tragedies of death. (1975) (1)
- The use of androgens in the treatment of diseases of the hematopoietic system (1977) (1)
- Hormone therapy for malignant myeloma. (1973) (1)
- Hormone therapy in inoperable breast cancer. (1969) (1)
- Severe neurotoxicity with methyl G: CALGB experience. (1982) (1)
- EFFECT OF CYCLOPHOSPHAMIDE (NSC-26271) ON FAR-ADVANCED NEOPLASIA. (1964) (1)
- Communicating with patients about advanced cancer. (1998) (1)
- Neutrophil leukocyte reserves in lymphoreticular malignancies. (1976) (1)
- Estrogen Receptor Assay-Reply (1977) (1)
- Hormone receptors in breast cancer and response to chemotherapy. (1979) (0)
- Book Review The Theory and Practice of Oncology: Historical evolution and present principles By Ronald W. Raven. 366 pp., illustrated. Park Ridge, N.J., Parthenon, 1990. $95. (1991) (0)
- Adriamycin (adr) cardiotoxicity: early assessment by creatine phosphokinase (cpk) isoenzymes. Abstr. (1981) (0)
- Lethal Nephrotoxicity and Hematologic Toxicity of Cis-Diamminedichloroplatinum Ameliorated by Optimal Circadian Timing and Hydration (1983) (0)
- Antiestrogens in Human Breast Cancer Up-Regulation of Estrogen Receptors by Nonsteroidal Updated (2006) (0)
- Breast cancer today. (1984) (0)
- of Human Fibroblast-like Cells in Culture * (2006) (0)
- Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma. (1996) (0)
- Human urinary pharmaco kinetics of cisplatin role of circadian drug timing (1981) (0)
- Characterization of newly synthesized, chiral tamoxifen analogs. (2004) (0)
- Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase II study. (1984) (0)
- THERAPEUTIC VERSUS PROPHYLACTIC CASTRATION IN BREAST CANCER. (1964) (0)
- Influence of constant enthalpy on broiler growth rate (1971) (0)
- HEMATOLOGIC EFFECT OF AN ETHYLENIMINE COMPOUND. (1963) (0)
- Studies with Tritiated Mithramycin in C 3 H Mice 1 (2006) (0)
- Effect of Adrenocortieotropie Hormone (AGTH) on Beryllium Granulomatosis and Silieosis. (1951) (0)
- Advanced cancer: New concepts of medical therapy. (1973) (0)
- Metabolic studies on the effects of crystalline growth hormone (somatotropin) in man. (1954) (0)
- Effect of Mithramycin on a Mouse Glioma1 (2006) (0)
- International symposium on chemotherapy in combination with hormonal therapy in breast cancer. An update586 Survival data of a combination versus sequential hormonal therapy add cytotoxic chemotherapy in advanced breast cancer (1983) (0)
- Mithramycin effect on the growth of a mouse glioma. Abstr. (1967) (0)
- A PROGESTOGEN FOR TREATMENT OF ADVANCED ENDOMETRIAL CANCER (1963) (0)
- Characterization of chiral tamoxifen analogs (2005) (0)
- Combination of radiation and mithramycin or dactinomycin therapy in a mouse glioma. Abstr. (1969) (0)
- Mechanism of the changes in hormonal dependency in mammary tumors. Abstr. (1981) (0)
- Gastric cancer - a continuing controversy: Does extra gastric lymphadenectomy (R2) alter survival? (1995) (0)
- Acute myeloid leukemia: treatment of with 6-mercaptopurine and cyclophosphamide. (1966) (0)
- Survival data of a combination versus sequential hormonal therapy and cytotoxic chemotherapy in advanced breast cancel (1983) (0)
- Letter: Granulocyte tranfusions in acute leukeamia. (1975) (0)
- HYDROXYUREA-ASSOCIATED LEG ULCERATION. AUTHORS' REPLY (1998) (0)
- Automatic anticancer chronotherapy using implanted programmable pumps: An attempt to improve therapeutic index (1986) (0)
This paper list is powered by the following services:
Other Resources About B. J. Kennedy
What Schools Are Affiliated With B. J. Kennedy?
B. J. Kennedy is affiliated with the following schools:
